Evox Therapeutics acquires exosome AAV technology from Codiak
Drug Discovery World
JUNE 22, 2023
This has been demonstrated to be an effective way to improve AAV delivery, to increase the breadth of expression in pre-clinical models, and to shield AAVs from neutralising antibodies. “We The post Evox Therapeutics acquires exosome AAV technology from Codiak appeared first on Drug Discovery World (DDW).
Let's personalize your content